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The temporal switch fromprogenitor cell proliferation
to differentiation is essential for effective adult tissue
repair. We previously reported the critical role of
Notch signaling in the proliferative expansion ofmyo-
genic progenitors in mammalian postnatal myogene-
sis. We now show that the onset of differentiation is
due to a transition fromNotch signaling toWnt signal-
ing inmyogenic progenitors and is associatedwith an
increased expression of Wnt in the tissue and an
increased responsiveness of progenitors to Wnt.
Crosstalk between these two pathways occurs via
GSK3b, which is maintained in an active form by
Notch but is inhibited byWnt in the canonicalWnt sig-
naling cascade. These results demonstrate that the
temporal balance between Notch and Wnt signaling
orchestrates the precise progression of muscle pre-
cursor cells along the myogenic lineage pathway,
through stages of proliferative expansion and then
differentiation, during postnatal myogenesis.
INTRODUCTION
Muscle regeneration in response to injury requires a careful or-
chestration of the activation and proliferation of muscle progen-
itor cells and their subsequent differentiation into multinucleated
myotubes to form newmuscle tissue. We have previously shown
that activation of the Notch signaling pathway is essential for the
early phases of this process, controlling activation of resident
muscle stem cells (satellite cells) and promoting the proliferation
of an intermediate progenitor cell population characterized by
expression of high levels of Pax3 (Conboy and Rando, 2002;
Boutet et al., 2007). However, little is known about the signaling
pathways that control the transition from proliferation to differen-
tiation in this population. Wnt signaling has been shown to be
necessary for muscle formation during embryogenesis (Cossu
and Borello, 1999) and has also been shown to have an essential
role in myogenic differentiation (Anakwe et al., 2003; Petropou-
los and Skerjanc, 2002) and myogenic stem cell fate in the adult
(Brack et al., 2007).50 Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc.Although it has been suggested that Wnt may indirectly affect
muscle regeneration by inducing a subpopulation of CD45+ cells
to adopt myogenic potential and, thus, potentially participate in
myogenesis (Polesskaya et al., 2003), the physiologic role of
CD45+ cells in muscle regeneration is uncertain (Sherwood
et al., 2004; Zammit et al., 2002). We sought to determine if
Wnt signaling may play an important role in postnatal myogene-
sis, akin to that in development, by acting directly on the bona
fide muscle stem cells and their progeny to control myogenic lin-
eage progression and therefore muscle regeneration.
In the current study, we show that Wnts act directly on myo-
genic progenitors, and the activation of this signaling cascade
results in the transition of progenitors from the proliferative
phase to the differentiation phase during postnatal myogenesis.
Furthermore, we show that the increase in Wnt signaling reflects
a critical transition from high Notch activation to highWnt activa-
tion and that this molecular switch is essential for effective mus-
cle regeneration. Importantly, the balance between these path-
ways is reflected by the state of activation of GSK3b, which is
maintained in the active state by Notch signaling and inactivated
by Wnt signaling. Thus, GSK3b is a pivotal determinant of cell
fate in muscle stem cell progeny, integrating inputs from the
Notch and Wnt signaling pathways.
RESULTS
Wnt Signaling Is Increased in Myogenic Progenitors
Progressively during Lineage Progression
and Muscle Regeneration
To investigate if activeWnt signaling was present in regenerating
muscle, we analyzed a downstream target of Wnt signaling,
Axin2 (Jho et al., 2002), in uninjured and regenerating muscle
(see Figure S1A available with this article online). Axin2 was up-
regulated in regeneratingmuscle. In order to assess the potential
role of canonical Wnt signaling in muscle progenitor cells during
postnatal myogenesis, we used the TOPGAL reporter mouse
(DasGupta and Fuchs, 1999). There was no detectable evidence
of Wnt signaling in uninjured muscle, but there was a striking
increase in Wnt signaling in many mononucleated cells within
regenerating muscle at 2 and 5 days after injury (Figure 1A). By
costaining for the myogenic lineage marker MyoD and for
b-galactosidase as an indication of active Wnt signaling, we
were able to confirm, both in vivo (Figure 1A, insert) and in vitro
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genic Lineage Progression and Muscle Regeneration
(A) Cross-sections of muscle from TOPGAL reporter mice after focal injury.
X-gal reactivity (blue) was observed in mononucleated cells in injured areas
at 2 days (left panel) and 5 days (right panel) of regeneration. (Insert, sections
stained for MyoD [green], b-galactosidase [red], and DAPI [blue]. MyoD+/
b-gal+ cells [arrows] were observed in regenerating areas, demonstratingmyo-
genic cells signaling through the canonical Wnt pathway. Nonmyogenic cells
that were responsive to Wnt [MyoD/ b-gal+; arrowhead] were also present.)(Figure 1B), that most myogenic progenitors in the regenerating
muscle were signaling through the canonical Wnt pathway. To
further investigate if myogenic progenitors signal via Wnt during
postnatal myogenesis, we isolated mononucleated cells from
myofiber explants. Approximately 92% of mononucleated cells
from fiber explants were positive for both Pax7 and Syndecan-
4 (sensitive and, in combination, specific markers of the myo-
genic lineage) as determined by FACS analysis (Figure 1C),
allowing for direct assessment of Wnt signaling in this popula-
tion. The levels of Wnt signaling increased in the satellite cell
progeny progressively with time in culture (Figure 1D and
Figure S1B).
We also analyzed the state of activation of GSK3b, a compo-
nent of the canonical Wnt signaling cascade, as an indication of
active Wnt signaling in myogenic progenitors. Dephosphoryla-
tion of GSK3b at tyrosine 216 is necessary for GSK3b to phos-
phorylate b-catenin and thereby promoting for canonical Wnt
signaling (Hagen et al., 2002; Yuan et al., 1999). FACS analysis
demonstrated that the fraction of myogenic cells with detectable
phosphorylated GSK3b at tyrosine 216 (GSK3bpY216) was rela-
tively high (indicative of low Wnt signaling) 1 day after injury (Fig-
ure 1E), a time when Notch signaling is high (Conboy and Rando,
2002). There was a progressive decline in the levels of
GSK3bpY216 from day 1 to day 4 (Figure 1E), consistent with in-
creased Wnt signaling seen by reporter gene expression in the
TOPGAL mice.
To test for the pattern of expression of canonical Wnts and
their receptors in muscle, we performed real-time qRT-PCR on
isolated myofiber explants with associated satellite cells after 1
or 4 days in culture. We observed an increase in canonical
Wnts after 4 days in culture, the largest increase being in Wnt
3A (Figure S1C). The Wnt receptors, Frizzled-1 and Frizzled-2,
also increased, as did Axin2. Therefore, ligand, receptor, and
a downstream target were all induced in preparations consisting
of only myofibers and activatedmyogenic progenitors. When the
myogenic progenitors were dissociated from the myofibers dur-
ing this time course and analyzed for ligand (Wnt3A) and receptor
(Frizzled-1) expression, an increase only in Frizzled-1 was de-
tected (Figure S1D). These data demonstrate that there is an
(B)Wnt signaling inmyogenic progenitors. Myogenic progenitors isolated from
regenerating muscle (3 days after injury) of TOPGAL mice were stained for
b-gal (red), MyoD (green), and DAPI (blue). Confirming results in vivo (insert,
[A]), myogenic cells were actively signaling through the Wnt cascade
(MyoD+/ b-gal+ cells).
(C) Mononucleated cells freshly isolated from bulk myofiber explants cultured
for 1 day were analyzed for Syndecan-4 (Syn4) and Pax7 expression by FACS.
Isotype controls are shown in the left panel. In these representative FACS
plots, 92% of cells were positive for both Syn4 and Pax7, demonstrating
a very high proportion of myogenic cells.
(D) Increased Wnt signaling during myogenic lineage progression. Myofibers
from TOPGAL mice were maintained in proliferation medium for 1–5 days. Pu-
rifiedmyogenic progenitor cells were stripped off the fibers (see Figure 1B) and
analyzed for b-gal activity. The levels of b-gal activity are presented relative to
the levels at day 1, demonstrating increased Wnt signaling during lineage pro-
gression in myogenic progenitors. Error bars, SEM. (*p < 0.05, **p < 0.01)
(E) Cells stripped off myofibers after 1–4 days in culture were analyzed for
Syndecan-4 and GSK3bpY216 expression by FACS. GSK3bpY216 is the active
form of GSK3b (GSK3b*) that declines when the canonical Wnt signaling cas-
cade is activated. Data are presented as the percentage Syndecan-4+ cells
that are GSK3b*+ (*p < 0.05).Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc. 51
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dent with an increased expression of Wnt in the tissue during
the process of muscle regeneration.
Wnt Signaling Promotes Myogenic Lineage Progression
and Premature Muscle Differentiation
Mononucleated cells isolated from single fiber cultures yield
a very pure myogenic population of cells (Rosenblatt et al.,
1995; Zammit et al., 2002). Nearly 100% of cells expressed
both Pax7 and MyoD 2 days after isolation and Desmin 3 to
4 days after isolation (Figures 2A and 2B). Over time in culture,
there was a progressive increase in the fraction of cells express-
ing Myogenin and Desmin and a decline in the fraction of cells
expressing Myf5 (Figures 2A and 2B). This expression pattern
was used to determine the state of differentiation in the myo-
genic progenitors when Wnt signaling was manipulated.
We used recombinant Wnt3A protein and a GSK3 inhibitor to
activate canonicalWnt signaling. In response to both treatments,
we observed an increase in Wnt reporter activity in myogenic
progenitors (Figure S2A). Furthermore, treatment of the cells
with Wnt3A resulted in an increase in the percentage of myo-
blasts expressing active b-catenin (Figure S2B) and nuclear
Figure 2. Expression of Myogenic Markers during Lineage Progres-
sion
(A) Single fibers were cultured and satellite cell progeny were immunostained
with a panel of antibodies (Pax7, MyoD, Desmin, and Myogenin) at different
times in culture. Nuclei were visualized with DAPI (blue).
(B) The percentages of cells expressing indicated proteins as determined in (A)
were quantified after various times in culture.52 Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc.localization of b-catenin, which was not observed in proliferating
myoblasts under control conditions (Figure S2C).
We analyzed the effects of activation of theWnt signaling path-
way on myogenic lineage progression. Myogenic progenitors
were isolated from regenerating muscle 2 days after injury. Rela-
tively few of the myogenic cells expressed Desmin (10%), as
determined by FACS analysis (Figure 3A). During a further
2 days in culture, the fraction of myogenic cells expressing Des-
min increased substantially (to45%). Strikingly, in cells treated
withWnt3A, therewas amuch greater increase in the percentage
of myogenic progenitors expressing Desmin (to 75%).
Single fiberswere isolated fromuninjuredmuscle, activated for
2 days, and either maintained overnight in control medium or
treated overnight with either exogenous Wnt3A or a GSK3 inhib-
itor to activate the Wnt pathway. Progenitor cells were then ana-
lyzed for the state ofmyogenic differentiation (see Figures 2A and
2B). Activation of Wnt signaling accelerated myogenic lineage
progression in progenitors activated ex vivo. After treatment
with Wnt3A or the GSK3 inhibitor, a larger percentage of cells
expressed high levels of Desmin (Figure 3B and Figure S3A).
There was also a lower percentage of cells expressingMyf5 (Fig-
ure S3B), concomitant with a decrease in proliferation (Figure
S3C). Thus, Wnt signaling is not only upregulated during myo-
genic lineage progression, but can promote myogenic commit-
ment and lineage progression in satellite cell progeny.
In order to confirm that these studies in vitro reflected the be-
havior of myogenic progenitors in vivo, Wnt3A was injected into
tibialis anterior muscles after freeze injury during the early prolif-
erative phase of myogenic progenitors (2 days after injury). The
muscles were analyzed 2 and 3 days later to determine the effect
of Wnt3A on myogenic lineage progression and early myogenic
differentiation. On day 4 after injury, myotubes in Wnt3A-treated
muscles were larger than in control muscles at this time point
(Figure 3C), and there was a greater number of nascent myo-
tubes compared to control muscles (Figure 3D), effects that
could be mimicked by injection of a GSK3 inhibitor (data not
shown). These findings reflect a premature induction of progen-
itor cell differentiation in vivo, are consistent with the effects
observed in vitro, and confirm that Wnt signaling facilitates line-
age progression and leads to accelerated differentiation during
postnatal myogenesis in vivo. However, this promotion of differ-
entiation did not result in an enhancement of muscle regenera-
tion. Between 4 and 5 days of regeneration, there was an in-
crease in the number of nascent fibers formed in control
muscles, whereas in Wnt-treated muscles, there was almost no
increase in fiber number (Figure 3D), an effect of the premature
differentiation and thus depletion of myogenic progenitors. The
end result was that there were large areas of injured muscle de-
void of new myofiber formation in Wnt-treated muscles
(Figure 3E). Therefore, the enhancement of differentiation by
exogenous Wnt3A during the early, proliferative phase was ulti-
mately detrimental to effective tissue regeneration.
Inhibition of Endogenous Wnt Signaling
Prevents Myogenic Lineage Progression
As a test of the role of endogenous Wnt signaling in satellite cell
activation and lineage progression, we added the soluble Wnt
inhibitor, sFRP3, to single fiber cultures at two different times
during myogenic lineage progression. Wnt was inhibited either
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Muscle Stem Cell Control via Notch and Wnt Signalingearly (day 2), when satellite cell progeny are rapidly expanding, or
later (day 3.5), when most progeny have progressed to further
commitment and differentiation (Zammit et al., 2004). When
sFRP3 was added early, no effect on cell fate was observed
compared to controls (Figure 4A). By contrast, inhibition of Wnt
produced a phenotype when added late, resulting in cultures
with a less differentiated phenotype. Therefore, endogenous
Wnt signaling acts directly on myogenic progenitors to promote
the progression from early, proliferating progenitors to more dif-
ferentiated progenitors.
We wanted to determine whether this temporal pattern of Wnt
activity in satellite cell progeny was observed in vivo during mus-
cle regeneration. Wnt was inhibited by an intramuscular sFRP3
injection either during the proliferative phase (day 2) or the differ-
entiation phase (day 3.5). There was no observable phenotype if
Wnt was inhibited during the proliferative phase. By contrast,
when the inhibitor was injected later, both the number and size
Figure 3. Exogenous Wnt Promotes Myogenic Lineage Pro-
gression and Differentiation
(A) Mononucleated cells freshly isolated from a regenerating muscle
(2 days after injury) were fixed for analysis or treated with Wnt
(100 ng/ml) or control (0.1% BSA) in proliferating conditions for
2 days. Cells were analyzed for Syndecan-4 (Syn4) and Desmin ex-
pression by FACS. Isotype controls are shown in the left panel. Rep-
resentative FACS plots are shown.
(B) ExogenousWnt3A (100 ng/ml) or control solution was added over-
night to single fiber cultures 2 days after isolation, and cells were an-
alyzed for Desmin expression (quantitative analysis shown in the right
panel; mean ± SEM) (*p < 0.05).
(C) Cross-sections ofmuscles after 4 days of regeneration treatedwith
either Wnt3A (10 ml of 100 ng/ml) or control solution (10 ml of 0.1%
BSA) 1.5 to 2 days after injury. Left, sections stained for embryonic
myosin heavy chain (eMHC, green) to identify newly formed myo-
tubes. Right, quantitative analysis of fiber size in control and Wnt3A-
treated muscles. Fiber size in regenerating area is relative to fiber
size in uninjured area and normalized to control muscles (mean ±
SEM) (*p < 0.05).
(D) Quantitative analyses of nascent fiber number normalized to cross-
sectional area of regenerating tissue in control and Wnt3A-treated
muscles analyzed after 4 and 5 days regeneration (mean ± SEM)
(*p < 0.05; **p < 0.001).
(E) Muscles were injected as in (C) and analyzed 5 days after injury.
Muscle cryosections were stained with H&E.
of nascent myotubes was decreased (Figures 4B and
4C). These data confirm that Wnt, acting directly on myo-
genic progenitors, is essential for normal muscle regener-
ation and that there is a critical temporal switch from early
Notch signaling to later Wnt signaling.
Because of the possibility that changes in endogenous
Wnt signaling could affect regeneration by acting on other
cells besides satellite cell progeny, we tested for Wnt sig-
naling in inflammatory cells that infiltrate areas of muscle
damage. Specifically, we tested for evidence of active
Wnt signaling in CD45+ cells, since it has been shown
that a subpopulation of CD45+ cellsmay respond to exog-
enous Wnt to adopt a myogenic fate (Polesskaya et al.,
2003). We found no evidence of active Wnt signaling in
the bulk population of CD45+ cells in resting or injured
muscle, all of which were lineage+ immune cells and
showednoevidenceof aproliferative response toWnt (FigureS4).
These data suggest that there is no significant contribution of
CD45+ cells to the population of progenitor cells that actively
regeneratemuscle and that the effects ofWnt signalingdescribed
here are not a reflection of any subpopulation of CD45+ cells.
The Notch Pathway Feeds into the Wnt Cascade
via GSK3b in Adult Myogenic Progenitors
To further characterize this temporal switch between Notch and
Wnt signaling, we used a soluble Jagged fusion protein (Jag-
ged1-Fc) to inhibit Notch signaling and a g-secretase inhibitor,
which has been shown to block Notch signaling in different cell
types, includingmyogenic progenitors (Dahlqvist et al., 2003). In-
hibition of Notch signaling promoted myogenic lineage progres-
sion both in vitro and in vivo (Figures 5A and 5B), thus confirming
previous results that Notch signaling maintains an early lineage
fate (Conboy and Rando, 2002; Conboy et al., 2003). However,Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc. 53
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phase in vivo (Figure 5B), the effects were negligible, indicating
a functional decline in Notch signaling at a timewhenWnt signal-
ing is increasing. This suggests a functional antagonism between
these two pathways.
In order to test for crosstalk between the Notch and Wnt sig-
naling pathways in myogenic progenitors, we first examined
readouts of Wnt signaling in cells in which Notch signaling was
altered. When Notch signaling was inhibited during the early pro-
liferative phase, we observed a premature increase in Wnt sig-
naling (Figure 6A), comparable to that seen in response to exog-
enous Wnt3A or GSK3 inhibition (Figure S2A), suggesting that
active Notch might suppressWnt signaling during this phase. In-
deed, direct activation of Notch using an activating antibody in
Wnt3A-treated myoblasts led to fewer cells expressing detect-
able nuclear-localized b-catenin (Figure 6B).
We next asked whether GSK3b, which is inactive in the pres-
ence of Wnt signaling and targets b-catenin for degradation,
was regulatedbyNotchsignaling.Weusedantibodies that recog-
nizeGSK3bwhen phosphorylated at serine 9 (GSK3bpS9) or at ty-
rosine 216 (GSK3bpY216); theseare readoutsof inactive andactive
GSK3b, respectively (Wang et al., 1994). Inhibition of Notch re-
sulted in a decline in GSK3bpY216 comparable to that seen in re-
sponse to Wnt3A (Figure 6C). Conversely, GSK3bpS9 staining
was increased when Notch was inhibited (Figure 6D), suggesting
that both inhibition of Notch and activation of Wnt signaling ap-
pear to inactivate GSK3b. Furthermore, direct activation of Notch
led to a significant increase in GSK3bpY216 compared to controls
as detected by FACS analysis (Figure S5). When Notch was acti-
vated in cells treated with Wnt 3A, the Wnt-induced inactivation
of GSK3b was partially inhibited (Figure 6E). Therefore, there is
Figure 4. Temporal Regulation ofWnt Signaling Is Necessary
for Lineage Progression and Effective Muscle Regeneration
(A) sFRP3 (30 ng/ml) was added overnight to single fiber cultures to in-
hibit Wnt either 2 days (‘‘early’’) or 3.5 days (‘‘late’’) after isolation. The
fraction of cells expressing an early myogenic lineagemarker (Myf5) or
late myogenic lineage markers (Desmin and Myogenin) were quanti-
fied (mean ± SEM). Histograms showing the state of myogenic lineage
progression, depending upon the timing of inhibition of Wnt signaling,
are shown (*p < 0.05).
(B) Injured muscle was injected with sFRP3 (10 ml of 30 ng/ml) or 0.1%
BSA (10 ml) either 2 days (‘‘Early’’) or 3.5 days (‘‘Late’’) after injury. Mus-
cles were analyzed after 5 days of regeneration by immunostaining for
eMHC (green) and DAPI (blue).
(C) Muscles treated as in (B) were analyzed by determining the number
of eMHC+ fibers in a normalized field from the regenerating area (left
histogram) and fiber size relative to control (right histogram; data ex-
pressed as mean ± SEM) in H&E-stained cryosections (*p < 0.05,
**p < 0.001).
clearly crosstalk between the Notch and Wnt cascade
reflected by the divergent regulation of GSK3b activation.
A Temporal Balance between Notch
and Wnt Signaling Is Necessary for Effective
Muscle Repair In Vivo
To investigate the balance between the Notch and Wnt
pathways in vivo, we activated these pathways individu-
ally or together during the phase of progenitor cell prolif-
eration. Activation of the Wnt pathway promoted differentiation,
albeit prematurely, reflected by the decreased fiber number and
larger fiber size (Figures 6F and 6G). Conversely whenNotchwas
activated, there was a marked inhibition of myogenesis both in
terms of number and size of nascent fibers, consistent with the
role of Notch in inhibition of lineage progression (Figure 5). Strik-
ingly, this block of myogenesis by enhanced Notch signaling
could be rescued by activation of the Wnt pathway via GSK3b
inhibition. These data further illustrate the fine balance between
Notch and Wnt signaling that is necessary for effective regener-
ation with GSK3b as a key nodal point at which these two path-
ways interact.
DISCUSSION
The results presented here reveal molecular regulatory pathways
involved in cell fate determination during postnatal myogenesis,
and provide new insights into functional and molecular interac-
tions between Notch and Wnt signaling pathways. We have
previously shown that Notch activity is necessary during early
activation and proliferation of satellite cells (Conboy et al.,
2003). The results of the current study demonstrate that Wnt sig-
naling is activated in myogenic progenitors later during lineage
progression, leading to the generation of fusion-competent myo-
blasts. Moreover, the effects of exogenous activators and inhib-
itors of Wnt signaling on adult myogenesis strongly suggest that
theWnt pathway is a key regulator of myogenic commitment and
terminal differentiation, consistent with findings during avian
wing development (Anakwe et al., 2003).
The upregulation of Axin2 suggests that Wnts are present and
actively signaling in regenerating muscle. Previous reports have54 Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc.
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and that the muscle fibers are the source of Wnt (Polesskaya
et al., 2003). A quantitative analysis of Wnt transcripts in regen-
erating muscle demonstrated that Wnts, such as Wnt5A, are ex-
pressed in uninjured muscle but appear to decrease during the
first 24 hr after injury, a time when the muscle tissue is degener-
ating, then are restored as the muscle is healed (Zhao and Hoff-
man, 2004). We observed an increase in transcript levels of
Wnt3A in myofibers isolated and placed in culture for 4 days.
The current data are consistent with expression of Wnts being
low during the early phase of regeneration, perhaps even reflect-
ing a decrease from resting levels consistent with previous
results (Zhao and Hoffman, 2004), when progenitor expansion
is occurring and then increase in injuredmuscle to promotemyo-
genic lineage progression. However, as important as the level of
ligand expression is the presence of their cognate receptors. We
have demonstrated that, during lineage progression, myogenic
progenitors express both receptors and downstream targets of
Wnt, arguing strongly that myogenic progenitors are signaling
through canonical Wnt signaling.
During muscle repair, the progenitor cells responsible for the
regenerative response are derived almost solely from the satel-
lite cell population (Zammit et al., 2002; Collins et al., 2005). It
has been reported that repeated daily injections of exogenous
Wnt promoted the myogenic conversion of CD45+ cells (Pole-
sskaya et al., 2003), but the physiological significance of these
rare cells in the process of muscle regeneration in vivo is
unknown. With daily injections of Wnt inhibitors, fewer desmin-
expressing cells were isolated from the regenerating muscle.
This is consistent with our data and our conclusion that inhibition
Figure 5. Inhibition of Notch Signaling Early during Satellite Cell
Activation Promotes Myogenic Lineage Progression
(A) After 2 days in culture, myogenic cells from single fiber cultures were
treated overnight with a g-secretase inhibitor (L-685,458) (2 mM) to inhibit
Notch signaling. Cells were immunostained for Myf5 and Desmin. Left, repre-
sentative image of Desmin staining; right, quantitative analysis (mean ± SEM)
(*p < 0.05, **p < 0.01).
(B) Injured muscle was injected with either a control solution (0.1%BSA [10 ml])
or a solution containing Jagged1-Fc (10 ml, 100 mg/ml) either 2 days (‘‘early’’) or
3.5 days (‘‘late’’) after injury. Muscles were analyzed after 5 days of regenera-
tion by H&E staining of cryosections. Early inhibition caused premature differ-
entiation, resulting in fewer but larger myotubes.of Wnt signaling prevents myogenic lineage progression, but is
likely due to the effects of the inhibitors on myogenic progenitors
rather than on CD45+ cells present in the regenerating tissue. In
fact, our studies show that daily injections of Wnt actually inter-
fere with, rather than enhance, muscle regeneration because of
the negative effects on early phases of myogenesis. Further-
more, our studies of resting and injured muscle suggest that
any CD45+ cells, responding to Wnt and adopting myogenic
properties, are likely to make only a very minor contribution, at
most, to muscle regeneration.
The timing of the regulation of the Wnt pathway is consistent
with the hypothesis that low Wnt activity is essential during pro-
liferative expansion of tissue-specific progenitor cells and that
increased Wnt activity promotes the progression of those cells
along themyogenic lineage (Figures 3A and 4A). Thus, a fine tun-
ing of the temporal pattern of Wnt signaling activity might regu-
late the expansion versus fusion of myoblasts. Consistent with
this prediction, exogenous Wnt added early during the prolifera-
tive phase of regeneration promoted premature differentiation;
there were more nascent fibers and they were larger. This had
a detrimental effect onmuscle regeneration as areas of the injury
area were devoid of nascent fibers (Figure 3E). Indeed, a high
level of Wnt signaling in quiescent and early activated satellite
cells during aging leads to progenitors losing their myogenic
fate and acquiring a fibrogenic fate (Brack et al., 2007). There-
fore, lowWnt signaling is required for the generation of adequate
numbers of myogenic progenitors. Inhibition of Wnt at this early
stage had negligible effects on the regenerative response (Fig-
ure 4), consistent with the relatively low level of Wnt signaling
in young myogenic progenitors. By contrast, inhibition of Wnt af-
ter the proliferation phase resulted in a delay of lineage progres-
sion and terminal differentiation. This pattern was opposite to
that of the Notch signaling pathway (Figure 5), where there was
impaired regeneration in vivo when Notch was inhibited early
but not late. Although levels of active Notch may continue to
be elevated at these late time points, the increase in expression
of Numbwould inhibit active Notch signaling, consistent with the
absence of any detectable effects of Notch inhibitors at these
time points. Thus, cell-fate determination along themyogenic lin-
eage is controlled by a precise balance between the (early) Notch
and (later) Wnt signal transduction pathways. The mechanisms
whereby Wnt promotes myogenic lineage progression and dif-
ferentiation and the downstream targets of Wnts that are acti-
vated or repressed during this process remain to be determined.
Interestingly, b-catenin can enhance the transcriptional activity
of the myogenic regulatory factors and thereby induce myosin
heavy-chain expression in P19 cells and promote differentiation
in myogenic cells (Pan et al., 2005; Pan et al., 2006). The binding
of b-catenin to myogenic determination genes is reminiscent of
b-catenin’s ability to bind to tissue-specific determination genes
during development (Olson et al., 2006).
The temporal balance between early Notch and later Wnt sig-
naling required for effective lineage progression and muscle re-
generation is controlled in part by Notch signaling feeding into
the Wnt cascade. We observed that Notch inhibition promoted
active signaling via the canonical Wnt cascade (Figure 6A),
whereas Notch activation inhibited the nuclear localization of
b-catenin observed in the presence of Wnt signaling (Fig-
ure 6B). Our results indicate GSK3b as a focal point of theCell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc. 55
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Ensures the Correct Balance for Normal Muscle Regener-
ation
(A) Myofiber-associated progenitors were stripped off myofibers
after 2 days in growth conditions. Cells were incubated in Wnt3A
(100 ng/ml) or the g-secretase inhibitor L-685,458 (5 ng/ml) over-
night. b-gal activity was measured and normalized to total protein
content, and the activity levels in the treated samples are presented
relative to control levels (mean ± SEM) (*p < 0.05, **p < 0.01).
(B) Primary myoblasts were treated with an activating Notch anti-
body or control IgG for 1 hr and subsequently plated for 17 hr in
media (5% horse serum in DMEM) containing Wnt (60 ng/ml) or
BSA (0.2%) as a control. The cultures were then analyzed for nu-
clear localization of b-catenin (red) by immunohistochemistry.
Representative images are shown on the left (arrows indicate
b-catenin+ nuclei; asterisk denotes b-catenin nucleus). Quanti-
tive analysis is shown on the right (mean ± SEM) (*p < 0.05).
(C) Western blotting was performed on extracts from progenitor
cells to test for changes in the levels of active GSK3b (‘‘GSK3b*’’,
determined as the level of GSK3b (pY216)) when the Wnt pathway
was activated by exogenous Wnt3A or the Notch pathway was in-
hibited by the g-secretase inhibitor, as in (A). Actin was used as
a loading control. Blots from replicate experiments were quanti-
fied, after normalization to Actin, to determine to the ratios of
GSK3b*/total GSK3b. The ratios were reduced to 41% ± 7% of
control by Wnt activation and 51% ± 10% of control by Notch
inhibition.
(D) Primary myoblasts were incubated in Wnt3A (60 ng/ml), the
g-secretase inhibitor, or control solution for 17 hr. Cells were
stained with a GSK3bS9 (green) antibody which reacts with the
serine 9 phosphorylated form of GSK3b and is a readout of the in-
active form of the enzyme. DAPI stains nuclei blue.
(E) Primary myoblasts were treated with control IgG or Notch
activating antibody, followed by incubation in Wnt3A or control
solution, and then analyzed by immunohistochemistry for
GSK3bS9 (green). Wnt3A treatment increased levels of GSK3bS9,
and this was partially prevented by incubation with the Notch ac-
tivating antibody. DAPI stains nuclei blue.
(F) Two and a half days after injury, muscles were injected with
either 10 ml of 0.1% BSA (‘‘Control’’), the GSK3 inhibitor
(0.35 ng/ml) to activate the Wnt pathway (GSK3inhib), the activat-
ing Notch antibody (1:4 dilution) to activate the Notch pathway
(Notch*), or both (Notch* + GSK3inhib). Five days after injury, cry-
osections were stained with H&E to assess the effectiveness of
muscle regeneration under these different conditions.
(G) Quantitation of results from experiments as described in (D) by
determining the fiber number (left panel) and fiber size (right panel;
normalized to control values) in regenerating muscles under the
different conditions (mean ± SEM) (*p < 0.05, **p < 0.001).crosstalk between Notch and Wnt pathways that is functionally
significant for the cell-fate determination in adult tissue repair.
Consistent with these findings, genetic screening of Notch
gain-of-function alleles in Drosophila identified the GSK3b
homolog, Shaggy, to be downstream of Notch signaling (Ruel
et al., 1993). It was shown that active GSK3b can phosphorylate
Notch-1 and -2 (Foltz et al., 2002; Espinosa et al., 2003), again
suggesting that this may represent a point of direct interaction
between Notch and Wnt signaling (Wesley, 1999; Axelrod
et al., 1996). GSK3b is a regulator that is at the crossroads of56 Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc.multiple signaling pathways, including those initiated by calcium
fluxes, G protein-coupled receptor activation, and Hedgehog
signaling, and participates in such diverse cellular glycogen
metabolism to cell-cycle regulation to tissue patterning (Doble
and Woodgett, 2003). We show that the antagonistic nature of
Notch and Wnt pathways is mediated by reciprocal effects on
the activation status of GSK3b in myogenic progenitor cells
(Figure 6B). GSK3b is inactivated by Wnt (Kim and Kimmel,
2000; Ding et al., 2000; Patel et al., 2004), although the precise
mechanism remains elusive. We show that GSK3b is active in
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Muscle Stem Cell Control via Notch and Wnt Signalingundifferentiated progenitors (Figure 1E), at a time when Notch
signaling is high (Conboy and Rando, 2002), and Wnts and their
receptors are low in the tissue. Furthermore, when Notch signal-
ing was directly activated, there was a corresponding increase in
the activation of GSK3b represented by increased phosphoryla-
tion at Y216 (Figure S5). When Notch signaling was maintained
in vivo (Figures 6C and 6D), which presumably maintained
GSK3b activity high, the addition of a GSK3 inhibitor was suffi-
cient to restore the balance and, more importantly, the normal
regeneration process.
The promotion ofmyogenic lineage progression by exogenous
Wnt was associated with a decrease in tyrosine phosphorylation
at residue 216 of GSK3b, consistent with previous results show-
ing the important role of the phosphorylation state of this residue
for b-catenin stabilization and, thus, downstream Wnt signaling
(Yuan et al., 1999; Hagen et al., 2002). We also observed an in-
crease in serine phosphorylation at residue 9 of GSK3b after
Wnt treatment, consistent with GSK3b being less active. Ding
et al. reported that phosphorylation of GSK3b at serine 9 in
CHO cells was not affected by a brief (10 min) treatment with
Wnt-conditioned media (Ding et al., 2000). There are many tech-
nical differences between that study and our studies presented
here to account for this difference. For example, the duration
of exposure to Wnt could be important. We did not observe
changes in GSK3bS9 even after 2 hr in Wnt3A, but changes
were evident after approximately 7 hr. Activation of Notch signal-
ing increased phosphorylation of tyrosine 216 of GSK3bwhereas
dephosphorylation of this residue was observed following treat-
ment of the cells with a Notch inhibitor. Consistent with the recip-
rocal effects of Notch and Wnt on GSK3b activity, activation of
Notch inhibited the increase of serine 9 phosphorylation due to
Wnt3A treatment. The regulation of the phosphorylation status
of GSK3b by Notch could involve the regulation of both kinases
and phosphatases that act on GSK3b (Kim et al., 2002). How-
ever, we cannot exclude the possibility that there are other points
of crosstalk between the Notch and Wnt pathways, upstream of
GSK3b, that fine tune the balance between these two function-
ally antagonistic pathways in myogenic progenitors.
We present a model of the balance between Notch and Wnt
signaling in satellite cell progeny, and the normal temporal
switch that occurs during lineage progression (Figure S6). This
balance serves to assure the production of the appropriate num-
bers of myogenic progenitors and to precisely regulate their cell
fate during postnatal myogenesis. During initial activation and
proliferation of satellite cells, Wnt signaling is low and the Notch
pathway is activated. Low Wnt signaling is due to both low se-
cretion of Wnt in the injured tissue, low expression of Wnt recep-
tors on myogenic progenitors, and repression of Wnt signaling
via Notch activation, reflecting the convergence of these two
pathways on the regulation of GSK3b activity in these cells.
Low Wnt signaling is necessary for myogenic progenitors to
maintain their fate soon after activation (Brack et al., 2007).
Once adequate numbers of progenitors have been generated,
Wnt signaling increases in the progenitors, whereas Notch activ-
ity begins to decrease because of the upregulation of Numb
(Conboy and Rando, 2002), consistent with the finding that
ectopic Wnt3A leads to the increase in Numb levels in somite
cultures from the chick (Holowacz et al., 2006). Due to the
crosstalk between the Notch and Wnt cascade via GSK3b, theinhibition of Notch signaling would facilitate the activation of
Wnt signaling further. The crosstalk between these two path-
ways via GSK3b is suitable for a rapid temporal switch to activate
the Wnt pathway and repress the Notch pathway, thus enabling
the rapid differentiation and fusion ofmyoblasts into nascentmy-
otubes. These studies also highlight a role of Wnt to promote lin-
eage progression rather than to maintain cells in a stem cell
stage (Reya and Clevers, 2005). We have recently shown that
Wnt can also cause myogenic progenitors to convert to a fibro-
genic fate if Wnt signaling is activated during quiescence or early
activation of adult myogenic stem cells (Brack et al., 2007).
Therefore, apparently opposing actions of Wnt signaling may re-
flect differential effects depending on the cellular context. More
generally, understanding the reciprocal roles of Notch and Wnt
signaling during muscle regeneration is essential for therapeutic
approaches that aim to regulate expansion versus differentiation
of myogenic progenitor cells to enhance tissue repair.
EXPERIMENTAL PROCEDURES
Animals
Two- to four-month-old C57BL/6 mice were obtained from Jackson Laborato-
ries (Bar Harbor, ME). TOPGAL mice were kindly provided by Elaine Fuchs
(Rockefeller University, NY). Animals were housed and handled in accordance
with the guidelines of Veterinary Medical Unit of the VA Palo Alto Health Care
System and the Administrative Panel on Laboratory Animal Care of Stanford
University.
Reagents
Antibodies to the following proteins (and sources) used were: Pax7 (DSHB);
Myogenin, total b-catenin, GSK3bpY216, and total GSK3b (PharMingen/Beck-
ton-Dickinson, San Jose, CA); actin and desmin (Sigma, St. Louis, MO); acti-
vated Notch-1 (Abcam, Cambridge, MA); activated (nonphosphorylated)
b-catenin and phospho-H3 (Upstate Biotechnology, Lake Placid, NY); and
GSK3bpS9 (Cell Signaling, Danvers, MA); b-galactosidase (Covance, Denver,
PA). The anti-Notch activating antibody used for in vivo injections was from
Upstate Biotechnology (hybridoma clone 8G10). The chicken polyclonal
Syndecan-4 antibody, eMHC antibody, and Myf5 antibody were generously
provided by Brad Olwin (University of Colorado), Grace Pavlath (Emory
University), and Dr. Steve Konieczny (Purdue University), respectively. Fluoro-
phore secondary conjugates used for immunofluorescence detection were
donkey-anti-chicken Alexa488, goat-anti-mouse APC, goat-anti-mouse
Alexa546, goat anti-rabbit Alexa488, and donkey-anti-rat Alexa488 (Molecular
Probes). Recombinant Jagged1-Fc, sFRP3, and Wnt3A proteins were from
R&D Systems (Minneapolis, MN). Inhibitors of g-secretase (L-685,458) and
GSK3 (BIO) were from Calbiochem (San Diego, CA).
Single Fiber Cultures, Explant Cultures, and Satellite Cell Isolation
Single fiber cultures, explant cultures, and satellite cell isolations were per-
formed as previously described were prepared as described previously
(Charge´ et al., 2002; Conboy and Rando, 2002). Details are presented in the
Supplemental Data.
Muscle Injury and Modulation of Notch
and Wnt Signaling in Regenerating Muscle
Injury to whole muscle was made by injection of barium chloride (50 ml, 1.2%)
into 30 sites in the lower limb. Focal injuries to tibialis anterior muscles were
made by applying a metal probe, 4 mm in diameter, that had been cooled
on dry ice directly to the exposed muscle surface for 10 s. To modulate Wnt
or Notch signaling, 10 ml of treatment (Wnt3A, sFRP3, GSK3 inhibitor, Jag-
ged1-Fc) or control solution was introduced into the muscle surrounding the
injury site by direct intramuscular injection at different times after the initial
injury. To activate Notch signaling, 10 ml of activating anti-Notch antibody
supernatant at a 1:4 dilution or an isotype-matched hamster IgG was injected
as previously described (Conboy et al., 2003). The GSK3 inhibitor andCell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc. 57
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ing into the injured muscle for experiments when they were to be added in
combination. To activate the Notch pathway in vitro, primary myoblasts
were incubated with activating anti-Notch antibody supernatant or isotype-
matched hamster control antibody as described previously (Conboy et al.,
2003). Cells were subsequently plated on ECM coated dishes in 5% HS/
DMEM and cultured for 1 hr at 37C, 5% CO2 and then isolated and prepared
for FACS analysis.
Histology and Immunofluorescence
Muscles were dissected and embedded for cryostat sectioning as previously
described (Conboy and Rando, 2002). Immunofluorescence was performed
on fixed cells (4% PFA, 10 min) after permeabilization with 0.2% Triton
X-100 in PBS (PBT) for 10min and block with 5%goat serum (GS) in PBT. Cells
were incubated in primary antibodies overnight at 4C at the following dilu-
tions: Myf5 (1/200), Pax7 (1/3), Desmin (1/120), Myogenin (1/100), phospho-
H3 (1/400), and BrdU (1/500). Cells were washed and blocked in 5% GS/
PBS and then incubated with fluorophore-conjugated antibody (Alexa goat
anti-mouse546 and goat anti-rabbit488 at 1/1500) and DAPI to visualize nuclei
for 1 hr at room temperature.
Analysis of Fiber Size and Fiber Number in Injured Area
At different times after muscle injury, the cross-sectional area of every regen-
erating muscle fiber (denoted by central nucleation) was quantified in the mid-
region of the injury using Axiovision AC software (Zeiss) and normalized to
cross-sectional areas of adjacent noninjuredmuscle fibers in H&E stained sec-
tions. The numbers of fiberswere counted in the regenerating areawithin a nor-
malized size field of view (203 objective). A minimum of three sections per
muscle was analyzed.
Fluorescent Activated Cell Sorting
Cells were fixed with 4% PFA. For detection of single antibodies, cells were
permeabilized with 5% FBS in 0.1% Triton X-100. Fixed cells were then
stained with primary antibodies or with isotype-matched control antibodies
for 1 hr at room temperature followed by incubation with fluorochrome-labeled
secondary antibodies (1/1000, goat anti-mouse Alexa 546, Molecular Probes)
for 1 hr at room temperature. For double antibody labeling experiments, the
primary antibodies were sequentially applied. Cells were blocked in 10% Blo-
kHen (Aves Labs, Tigard, OR) for 30 min and stained with the Syndecan-4 an-
tibody (1/500) for 1 hr. Cells were washed and blocked in 5% GS in 0.1% PBT
for 15 min. Secondary antibody (1/1500; goat-anti-chick Alexa 488, Molecular
probes) was applied for 1 hr. Cells were then washed and fixed in 4% PFA for
5 min. The second antibody (goat anti-mouse APC) was then applied using the
same protocol as single antibody labeling. Cells were analyzed by FACSca-
liber (Beckton-Dickinson).
Western Blotting
For western analysis, cells were lysed in RIPA buffer (50 mM Tris-HCl, 1 mM
EDTA, 1 mM EGTA, 150 mM NaCl, 1% NP-40) containing 90 mg/ml PMSF,
20 mg/ml aprotinin, and 20 mg/ml leupeptin (Sigma). Immunoblotting was per-
formed as previously described (Conboy et al., 2003).
Detection of b-Galactosidase in TOPGAL mice
For histological analysis, muscle sections were fixed in 0.2% glutaraldehyde
for 10 min, and stained with X-gal. For biochemical analysis, muscle was ho-
mogenized in 0.1% SDS in RIPA buffer and analyzed for total protein (BCA
kit, Pierce) and b-gal activity (Galacto-light, Tropix).
Real Time RT-PCR
RNA was isolated from muscle using TRIZOL reagent (Invitrogen) and cDNA
was synthesized using Superscript First Strand Synthesis System for RT-
PCR (Invitrogen) according to manufacturer’s instructions. Relative quantita-
tion by real-time PCR was carried out using SYBR-green detection of PCR
products in real time using the MyiQ single-color detection system (Biorad).
In each experiment, GAPDH gene was amplified as the reference standard.
Each real-time PCR reaction (25 ml) contained 2 ml of cDNA, 10 ml of 2X
SYBR Green Master Mix (Applied Biosystems Inc. Foster City, CA), including58 Cell Stem Cell 2, 50–59, January 2008 ª2008 Elsevier Inc.Amplitaq polymerase (Perkin-Elmer), and primers (available on request) at
a final concentration of 20 pM.
Gene expression was quantitated using an ABI SYBR green PCR detection
system (Applied Biosystem). All reactions were performed using the following
thermal cycler conditions: 95C for 10min followed by 45 cycles of a three step
reaction, denaturation at 95C for 30 s, annealing at 60C for 2 min, and exten-
sion and data collection at 72C for 30 s.
Statistical Analysis
A minimum of 3 and up to 5 replicates was done for experiments presented.
Data are presented as means and standard errors of the mean. Comparisons
between groups were done using Kruskall Wallis comparison and a Dunn’s
multiple comparison post hoc test. Differences were considered statistically
significant at the p < 0.05 level.
Supplemental Data
The Supplemental Data include Supplemental Experimental Procedures and
six figures and can be found with this article online at http://www.
cellstemcell.com/cgi/content/full/2/1/50/DC1/.
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